The coronavirus outbreak has stretched renewal negotiations in the directors’ and officers’ (D&O) market, with underwriters ramping up company scrutiny and in some instances attempting to introduce coronavirus exclusions.
The coronavirus outbreak has stretched renewal negotiations in the directors’ and officers’ (D&O) market, with underwriters ramping up company scrutiny and in some instances attempting to introduce coronavirus exclusions.